All the talks of waiting is scary to me. I am failing to see any benefits of waiting if we consider BO is a better option which is.
EMA is not a hurdle, neither is appeal if two parties are serious about acquisition. These only become problems if either/both parties are not interested or want to nickle and dime the deal.
If someone thinks wait will get more, wrong! Time is not free as we all know.
Vascepa could possibly reach $1B revenue this year if Amarin can go full monty on marketing. Here is a case - assume the marketing budget for Vascepa is $100M this year. It's 18% of Amarin's cash. So yes Amarin has to cut it to preserve cash while figuring out the appeal and EU. However, if V is in a BP's hand, $100M is not a big deal for BP. So why not just blast it and get the revenue and profit now! After ReduceIt topline, AZN still drove its STRENGTH to the end for a year. That's easily $100M wasted. When you have only $600 in the bank, the way you make decision is very different from the case that you have $10K in the bank.
Amarin has failed to convince the only person in the US that matters about the difference between EPA and fish oil. That person is Miranda Du who is well educated and is obligated to read all the information about Vascepa. Do we really want to believe that Amarin can build a differentiated brand on its own? and in n number of different languages in m number of different markets?
As shareholders, we all need to stop talking and thinking about wait. We need to start talking about how we want to sell the company and urge the company to do so!
